185 related articles for article (PubMed ID: 30039266)
21. [A case of anti-nuclear matrix protein 2 antibody positive myopathy associated with lung cancer].
Ohta S; Unoda K; Nakajima H; Ikeda S; Hamaguchi Y; Kimura F
Rinsho Shinkeigaku; 2016 Aug; 56(8):573-6. PubMed ID: 27477574
[TBL] [Abstract][Full Text] [Related]
22. Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options.
Fredi M; Bartoli F; Cavazzana I; Ceribelli A; Carabellese N; Tincani A; Satoh M; Franceschini F
Clin Exp Rheumatol; 2017; 35(2):303-308. PubMed ID: 27908312
[TBL] [Abstract][Full Text] [Related]
23. A multianalyte assay for the detection of dermatomyositis-related autoantibodies based on immunoprecipitation combined with immunoblotting.
Kuwana M; Okazaki Y
Mod Rheumatol; 2023 Apr; 33(3):543-548. PubMed ID: 35662349
[TBL] [Abstract][Full Text] [Related]
24. Rare myositis-specific autoantibody associations among Hungarian patients with idiopathic inflammatory myopathy.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Jobanputra R; Dankó K
Acta Reumatol Port; 2015; 40(4):337-47. PubMed ID: 26922197
[TBL] [Abstract][Full Text] [Related]
25. [Myositis-specific autoantibodies].
Fujimoto M
Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
[TBL] [Abstract][Full Text] [Related]
26. Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.
Valenzuela A; Chung L; Casciola-Rosen L; Fiorentino D
JAMA Dermatol; 2014 Jul; 150(7):724-9. PubMed ID: 24869801
[TBL] [Abstract][Full Text] [Related]
27. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
[TBL] [Abstract][Full Text] [Related]
28. A case of haemorrhagic myositis with concurrent anti-Ro52 and anti-NXP-2 antibodies treated with plasmapheresis.
Brown ZR; Thomas JS; Limaye V
Rheumatology (Oxford); 2020 Mar; 59(3):682-684. PubMed ID: 31504945
[No Abstract] [Full Text] [Related]
29. Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects.
Wodkowski M; Hudson M; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Tatibouet S; Wang M; ; ; ; Baron M; Fritzler MJ
Autoimmunity; 2015; 48(8):542-51. PubMed ID: 26334795
[TBL] [Abstract][Full Text] [Related]
30. Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis.
Pinal-Fernandez I; Pak K; Gil-Vila A; Baucells A; Plotz B; Casal-Dominguez M; Derfoul A; Martinez-Carretero MA; Selva-O'Callaghan A; Sabbagh S; Casciola-Rosen L; Albayda J; Paik J; Tiniakou E; Danoff SK; Lloyd TE; Miller FW; Rider LG; Christopher-Stine L; Mammen AL;
Arthritis Rheumatol; 2022 Feb; 74(2):358-364. PubMed ID: 34313394
[TBL] [Abstract][Full Text] [Related]
31. Perimysial microarteriopathy in dermatomyositis with anti-nuclear matrix protein-2 antibodies.
Liu Y; Zheng Y; Gang Q; Xie Z; Jin Y; Zhang X; Deng X; Hao H; Gao F; Zhang Z; Xiong H; Zhang W; Wang Z; Yuan Y
Eur J Neurol; 2020 Mar; 27(3):514-521. PubMed ID: 31571350
[TBL] [Abstract][Full Text] [Related]
32. [Clinical and immunological characteristics of myositis complicated with thromboembolism].
Zhu FY; Xing XY; Tang XF; Li YM; Shao M; Zhang XW; Li YH; Sun XL; He J
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):995-1000. PubMed ID: 33331304
[TBL] [Abstract][Full Text] [Related]
33. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.
Selva-O'Callaghan A; Labrador-Horrillo M; Solans-Laque R; Simeon-Aznar CP; Martínez-Gómez X; Vilardell-Tarrés M
Arthritis Rheum; 2006 Oct; 55(5):791-8. PubMed ID: 17013837
[TBL] [Abstract][Full Text] [Related]
34. Two young-adult female cases of dermatomyositis with antibodies for transcriptional intermediary factor 1-γ.
Matsuura E; Ishiguro N; Katsumata Y; Urano W; Yamanaka H; Kondo M; Kuwana M; Kaji K; Hamaguchi Y; Fujimoto M; Kawashima M
Eur J Dermatol; 2012; 22(5):668-71. PubMed ID: 22992252
[TBL] [Abstract][Full Text] [Related]
35. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.
Betteridge ZE; Gunawardena H; Chinoy H; North J; Ollier WE; Cooper RG; McHugh NJ;
Ann Rheum Dis; 2009 Oct; 68(10):1621-5. PubMed ID: 18930994
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement.
Kaji K; Fertig N; Medsger TA; Satoh T; Hoshino K; Hamaguchi Y; Hasegawa M; Lucas M; Schnure A; Ogawa F; Sato S; Takehara K; Fujimoto M; Kuwana M
Arthritis Care Res (Hoboken); 2014 Apr; 66(4):575-84. PubMed ID: 24023044
[TBL] [Abstract][Full Text] [Related]
37. Anti-mitochondrial antibodies in Indian patients with idiopathic inflammatory myopathies.
Gaur PS; R N; Anuja AK; Singh MK; Rai MK; Muhammed R; Sahu AK; Agarwal V; Gupta L
Int J Rheum Dis; 2022 Jun; 25(6):659-668. PubMed ID: 35384316
[TBL] [Abstract][Full Text] [Related]
38. The phenotype of myositis patients with anti-Ku autoantibodies.
Casal-Dominguez M; Pinal-Fernandez I; Derfoul A; Graf R; Michelle H; Albayda J; Tiniakou E; Adler B; Danoff SK; Lloyd TE; Christoper-Stine L; Paik JJ; Mammen AL
Semin Arthritis Rheum; 2021 Aug; 51(4):728-734. PubMed ID: 34144382
[TBL] [Abstract][Full Text] [Related]
39. Calcinosis in Juvenile Dermatomyositis-Epidemiology, Pathogenesis, Clinical Features, and Treatment: A Systematic Review.
Gonçalves Júnior J; Shinjo SK
Curr Rheumatol Rep; 2024 Feb; 26(2):53-68. PubMed ID: 38060107
[TBL] [Abstract][Full Text] [Related]
40. Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation.
Aggarwal R; Oddis CV; Goudeau D; Fertig N; Metes I; Stephens C; Qi Z; Koontz D; Levesque MC
Rheumatology (Oxford); 2014 Mar; 53(3):433-7. PubMed ID: 24255164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]